{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:31:18Z","timestamp":1743276678965,"version":"3.33.0"},"reference-count":122,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,12,17]],"date-time":"2007-12-17T00:00:00Z","timestamp":1197849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>A cytomegalovirus (CMV) donor positive\/recipient negative liver transplant recipient developed CMV syndrome with presumed colitis 2 weeks after discontinuing the standard 3 months of valganciclovir prophylaxis. Treatment with intravenous ganciclovir (GCV) reduced, but did not clear, CMV replication. A CMV UL97 mutation (M460V) conferring GCV resistance was identified. Reduction of immunosuppression was followed by rapidly rising lymphocyte counts as well as by clearance of CMV viremia and of clinical symptoms. However, bilateral chorioretinitis was diagnosed 2 weeks later and treated with foscarnet and cidofovir. Then, right eye vitritis occurred necessitating vitrectomy due to a partially rhegmatogeneous retinal detachment. Because chorioretinitis\u2013vitritis after rising lymphocyte counts and clearance of CMV viremia was strongly suggestive of an immune reconstitution syndrome (IRS)\u2010like disease, we investigated CMV\u2010specific T\u2010cells in the peripheral blood available during follow\u2010up. We found strong CD8<jats:sup>+<\/jats:sup>but only low CD4<jats:sup>+<\/jats:sup>T\u2010cell responses (4.77% vs.&lt;0.1%) to the CMV immediate early pp72, while responses to CMV\u2010lysate or CMV\u2010pp65 (CD4<jats:sup>+<\/jats:sup>&lt;0.01%; CD8<jats:sup>+<\/jats:sup>&lt;0.01%) were low. Over 16 weeks of follow\u2010up, pp72\u2010specific CD8<jats:sup>+<\/jats:sup>responses declined, while responses to pp65 gradually increased (CD4<jats:sup>+<\/jats:sup>0.16%; CD8<jats:sup>+<\/jats:sup>0.76%) indicating a slowly adapting CMV\u2010specific cellular T\u2010cell response. Review of 12,653 published liver transplant patients identified only 14 (0.1%) reported cases of CMV\u2010associated chorioretinitis at a median 41.7 weeks post transplant. CMV\u2010associated opthalmologic complications late post transplantation may possibly involve 2 different entities of cytopathic retinitis and IRS\u2010like chorioretinitis\u2013vitritis.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2007.00285.x","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T09:54:15Z","timestamp":1201686855000},"page":"27-43","source":"Crossref","is-referenced-by-count":27,"title":["Cytomegalovirus\u2010associated chorioretinitis after liver transplantation: case report and review of the literature"],"prefix":"10.1111","volume":"10","author":[{"given":"A.","family":"Egli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bergamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"M\u00fcllhaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Seebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.6.1223"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11431-8"},{"key":"e_1_2_6_4_2","first-page":"169","article-title":"Immune recovery vitritis associated with inactive cytomegalovirus retinitis","volume":"116","author":"Karavellas MP","year":"1998","journal-title":"a new syndrome"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131375.21070.06"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/314639"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/383034"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki444"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000180530.17683.02"},{"key":"e_1_2_6_10_2","first-page":"354","article-title":"BK virus","volume":"41","author":"Hirsch HH.","year":"2005","journal-title":"opportunity makes a pathogen"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000165096.01034.15"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm283"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200105150-00018"},{"issue":"8","key":"e_1_2_6_14_2","first-page":"72","article-title":"Cytomegalovirus and polyomavirus BK posttransplant","volume":"22","author":"Egli A","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00797.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390220080025"},{"key":"e_1_2_6_17_2","first-page":"124","article-title":"Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients","volume":"158","author":"Singh N","year":"1988","journal-title":"transmission by donated organ and the effect of OKT3 antibodies"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/jcm.26.12.2531-2535.1988","article-title":"Comparison between viremia and antigenemia for detection of cytomegalovirus in blood","volume":"26","author":"Van der Bij W","year":"1988","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198807000-00015"},{"key":"e_1_2_6_20_2","first-page":"752","article-title":"Cytomegalovirus hepatitis in liver transplantation","volume":"160","author":"Paya CV","year":"1989","journal-title":"prospective analysis of 93 consecutive orthotopic liver transplantations"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65346-4"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410120093018"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.1.63"},{"key":"e_1_2_6_24_2","first-page":"1307","article-title":"Cytomegalovirus infections in pediatric liver transplantation","volume":"144","author":"King SM","year":"1990","journal-title":"Am J Dis Child"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(91)90835-H"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1128\/jcm.30.7.1876-1878.1992","article-title":"Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients","volume":"30","author":"Delgado R","year":"1992","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1993.tb01649.x"},{"key":"e_1_2_6_28_2","first-page":"185","article-title":"Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation","volume":"18","author":"Paya CV","year":"1993","journal-title":"a prospective multivariate time-dependent analysis"},{"key":"e_1_2_6_29_2","first-page":"13","article-title":"Diagnosis and monitoring of cytomegalovirus infection after liver transplantation in children","volume":"1","author":"Kalicinski P","year":"1993","journal-title":"Ann Transplant"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-10-199311150-00004"},{"key":"e_1_2_6_31_2","first-page":"2282","article-title":"Cytomegalovirus disease in liver transplant recipients","volume":"25","author":"Kizilisik TA","year":"1993","journal-title":"impact of acyclovir prophylaxis"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/jcm.32.11.2655-2659.1994","article-title":"Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis","volume":"32","author":"Manez R","year":"1994","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/jcm.32.6.1431-1434.1994","article-title":"Detection of cytomegalovirus DNA in sera of liver transplant recipients","volume":"32","author":"Patel R","year":"1994","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199410150-00005"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-5-199403010-00004"},{"issue":"5","key":"e_1_2_6_36_2","first-page":"23","article-title":"A further analysis of the use of cytomegalovirus immune globulin prophylaxis in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplant CMVIG\u2010Study Group","volume":"26","author":"Snydman DR","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02090054"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.644"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.2.389-394.1995"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199501150-00007"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1995.tb01491.x"},{"key":"e_1_2_6_42_2","first-page":"1357","article-title":"Long\u2010term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection","volume":"60","author":"Winston DJ","year":"1995","journal-title":"Transplantation"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.1014"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92110-9"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500010611"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199606270-00009"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.5.1072"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.2.446"},{"key":"e_1_2_6_49_2","first-page":"292","article-title":"Primary cytomegalovirus infection in liver transplant recipients","volume":"23","author":"Falagas ME","year":"1996","journal-title":"comparison of infections transmitted via donor organs and via transfusion. Boston Center for Liver Transplantation CMVIG Study Group"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1996.tb01594.x"},{"key":"e_1_2_6_51_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1399-0012.1997.tb00828.x","article-title":"Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation","volume":"11","author":"McVicar JP","year":"1997","journal-title":"Clin Transplant"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1997.tb00725.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0012.1997.tb00847.x","article-title":"Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group","volume":"11","author":"Falagas ME","year":"1997","journal-title":"Clin Transplant"},{"key":"e_1_2_6_54_2","first-page":"66","article-title":"Prophylaxis of cytomegalovirus infection in transplantation","volume":"64","author":"Badley AD","year":"1997","journal-title":"a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199712150-00022"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199701150-00013"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05535-9"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1086\/516095"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1086\/516139"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1086\/513655"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.4.423"},{"key":"e_1_2_6_62_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0012.1998.tb00974.x","article-title":"A randomized, placebo\u2010controlled trial with anti\u2010interleukin\u20102 receptor antibody for immunosuppressive induction therapy after liver transplantation","volume":"12","author":"Langrehr JM","year":"1998","journal-title":"Clin Transplant"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00036"},{"key":"e_1_2_6_64_2","first-page":"1020","article-title":"Significance of cytomegalovirus for long term survivial after orthotopic liver transplantation","volume":"66","author":"Falagas ME","year":"1998","journal-title":"a prospective derivation and validation cohort analysis"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199806150-00012"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199801270-00006"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199809150-00007"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1086\/513949"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010202.x"},{"key":"e_1_2_6_70_2","first-page":"2","article-title":"Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients","volume":"2","author":"Turgeon N","year":"2000","journal-title":"effect of oral ganciclovir"},{"key":"e_1_2_6_71_2","first-page":"717","article-title":"Cytomegalovirus antigenemia directed pre\u2010emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients","volume":"70","author":"Singh N","year":"2000","journal-title":"a randomized, controlled trial"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1086\/317636"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2000.00095.x"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2000.020303.x"},{"key":"e_1_2_6_75_2","first-page":"118","article-title":"Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients","volume":"2","author":"K\u00fcnzle N","year":"2000","journal-title":"relationship between compliance with the guidelines and prevention of CMV morbidity"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)00879-4"},{"key":"e_1_2_6_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)01599-2"},{"key":"e_1_2_6_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101270-00009"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109150-00024"},{"key":"e_1_2_6_80_2","doi-asserted-by":"publisher","DOI":"10.1086\/324516"},{"key":"e_1_2_6_81_2","first-page":"2571","article-title":"Use of combination cytomegalovirus immune globuline plus ganciclovir for prophylaxis in CMV\u2010seronegative liver transplant recipients of a CMV\u2010seropositive donor organ","volume":"33","author":"Snydman DR","year":"2001","journal-title":"a multicenter, open-label study"},{"key":"e_1_2_6_82_2","first-page":"30","article-title":"Cytomegalovirus infection in liver transplant recipients","volume":"1","author":"Fan J","year":"2002","journal-title":"Hepatobiliary Pancreas Dis Int"},{"key":"e_1_2_6_83_2","first-page":"527","article-title":"Cytomegalovirus infection after liver transplantation","volume":"74","author":"Norris S","year":"2002","journal-title":"viral load as a guide to treating clinical infection"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.21012.x"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2002.00510.x"},{"key":"e_1_2_6_86_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.8.2945-2952.2002"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.32282"},{"key":"e_1_2_6_88_2","first-page":"854","article-title":"Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients","volume":"185","author":"Paya CV","year":"2002","journal-title":"a randomized, placebo-controlled trial"},{"key":"e_1_2_6_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00810-8"},{"key":"e_1_2_6_90_2","first-page":"104","article-title":"Cytomegalovirus disease following liver transplantation","volume":"47","author":"Singhal S","year":"2003","journal-title":"an analysis of prophylaxis strategies"},{"key":"e_1_2_6_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/375194"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2003.tb00255.x"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000145989.22373.03"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000142619.01510.A5"},{"key":"e_1_2_6_95_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-3046.2003.00131.x"},{"key":"e_1_2_6_96_2","first-page":"728","article-title":"Interleukin\u20102 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation","volume":"10","author":"Liu CL","year":"2004","journal-title":"a protocol with early elimination of steroids and reduction of tacrolimus dosage"},{"key":"e_1_2_6_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000093463.86584.AC"},{"key":"e_1_2_6_98_2","first-page":"93","article-title":"T\u2010helper cell responses in liver transplant recipients","volume":"6","author":"Singh N","year":"2004","journal-title":"correlation with cytomegalovirus and other major infections"},{"key":"e_1_2_6_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2006.00140.x"},{"key":"e_1_2_6_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20520"},{"key":"e_1_2_6_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2005.00093.x"},{"key":"e_1_2_6_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.06.063"},{"key":"e_1_2_6_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20417"},{"key":"e_1_2_6_104_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2005.00162.x"},{"key":"e_1_2_6_105_2","first-page":"85","article-title":"Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients","volume":"79","author":"Singh N","year":"2005","journal-title":"impact on viral load and late-onset cytomegalovirus disease"},{"key":"e_1_2_6_106_2","first-page":"197","article-title":"Risk factors of cytomegalovirus infection after living donor liver transplantation","volume":"52","author":"Akamatsu N","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_107_2","first-page":"138","article-title":"Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients","volume":"33","author":"Martin\u2010Davila P","year":"2005","journal-title":"an intent to find the optimal cut-off value"},{"key":"e_1_2_6_108_2","first-page":"537","article-title":"Monitoring human cytomegalovirus (HCMV) in HCMV\u2010seropositive orthotopic liver\u2010transplant recipients by means of quantitative real\u2010time polymerase chain reaction","volume":"4","author":"Mengelle C","year":"2006","journal-title":"Exp Clin Transplant"},{"key":"e_1_2_6_109_2","first-page":"21","article-title":"Cytomegalovirus infections of the liver transplant","volume":"8","author":"Lautenschlager I","year":"2006","journal-title":"virological, histological, immunological, and clinical observations"},{"key":"e_1_2_6_110_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1029"},{"key":"e_1_2_6_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20562"},{"key":"e_1_2_6_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000226071.12562.1a"},{"key":"e_1_2_6_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.06.075"},{"key":"e_1_2_6_114_2","first-page":"915","article-title":"Quantitation of cytomegalovirus DNA by real\u2010time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants","volume":"78","author":"Allice T","year":"2006","journal-title":"comparison with end-point PCR and pp65 antigen test"},{"key":"e_1_2_6_115_2","doi-asserted-by":"publisher","DOI":"10.1086\/511307"},{"key":"e_1_2_6_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01488.x"},{"key":"e_1_2_6_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01890.x"},{"key":"e_1_2_6_118_2","doi-asserted-by":"publisher","DOI":"10.1086\/430606"},{"key":"e_1_2_6_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(01)00200-1"},{"key":"e_1_2_6_120_2","doi-asserted-by":"publisher","DOI":"10.1086\/340636"},{"key":"e_1_2_6_121_2","doi-asserted-by":"publisher","DOI":"10.1086\/324419"},{"key":"e_1_2_6_122_2","doi-asserted-by":"publisher","DOI":"10.1086\/382964"},{"key":"e_1_2_6_123_2","doi-asserted-by":"publisher","DOI":"10.1086\/342044"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2007.00285.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2007.00285.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T11:55:34Z","timestamp":1737892534000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2007.00285.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,17]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1399-3062.2007.00285.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2007.00285.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"type":"print","value":"1398-2273"},{"type":"electronic","value":"1399-3062"}],"subject":[],"published":{"date-parts":[[2007,12,17]]}}}